首页> 外文OA文献 >A3-06: Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: preliminary results of a multicenter randomized factorial study

【2h】

A3-06: Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: preliminary results of a multicenter randomized factorial study

机译：A3-06：在IIIB-IV期非小细胞肺癌（NSCLC）患者的一线治疗中，三联与含或不含顺铂的双联：多中心随机因子研究的初步结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Boni Corrado; Baldini Editta; Boni Luca; Tiseo Marcello; Recchia Francesco; Barone Carlo; Manzione Luigi; Zanelli Francesca; Prochilo Tiziana; Ardizzoni Andrea;
展开▼
作者单位

展开▼
年度 2007
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB|[ndash]|IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST) [J] . C Boni, M Tiseo, L Boni, British Journal of Cancer . 2012,第4期

机译：一线治疗IIIB | n | IV期非小细胞肺癌（NSCLC）患者的一线治疗中，三联体与双联体（有或没有顺铂）：一项多中心随机因子试验（FAST）
2. AvaALL: Open-Label Randomized Phase 1Mb Trial Evaluating the Efficacy and Safety of Standard of Care With or Without Continuous Bevacizumab (BV) Treatment Beyond Disease Progression in Patients (pts) With Advanced Nonsquamous Non-Small Cell Lung Cancer (NSCLC) After First-Line (1L) Treatment With BV Plus Platinum-Doublet Chemotherapy (CT) [J] . Clinical advances in hematology & oncology: H&O . 2012,第Suppla11期

机译：AvaALL：开放标签随机1Mb临床试验，评估在初次手术后晚期非鳞状非小细胞肺癌（NSCLC）患者病情进展之外，是否进行持续贝伐单抗（BV）治疗的标准治疗的有效性和安全性BV加上铂金双线化疗（CT）的线（1L）治疗
3. Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan (vol 129, pg 55, 2019) [J] . Watanabe Satoshi, Yoshioka Hiroshige, Sakai Hiroshi, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2019,第期

机译：Necitumumab Plus Gemcitabine和Cisplatin与吉西他滨和顺铂单独作为阶段IV鳞状非小细胞肺癌的一线治疗：阶段1B和随机开放的标签，多中心，日本第2阶段试验（第129 Vol 129，PG 55， 2019）
4. Does Sex Make a Difference in Survival of Patients Undergoing Resection for Early Stage Non-Small Cell Lung Cancer (NSCLC)? [C] . Steven J.Jubelirer, Nicole L.Varela, Christine A.Welch, 21st international conference on screening for lung cancer . 2009

机译：性别对早期非小细胞肺癌（NSCLC）切除患者的生存率有影响吗？
5. Pre-Treatment Radiomics Models for Clinical Outcomes in Early-Stage Non-Small Cell Lung Cancer (NSCLC) [D] . Shaffer, Nathan Allen. 2021

机译：早期非小细胞肺癌临床结果的预处理辐射瘤模型（NSCLC）
6. Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB–IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST) [O] . C Boni, M Tiseo, L Boni, 2012

机译：一线治疗IIIB–IV期非小细胞肺癌（NSCLC）患者的三联与双联有或没有顺铂：一项多中心随机因子试验（FAST）
7. 1320_PR: Subgroup analyses of patients with epidermal growth factor receptor (EGFR)-expressing tumors in SQUIRE: A randomized, multicenter, open-label, phase III study of gemcitabine–cisplatin (GC) plus necitumumab (N) versus GC alone in the first-line treatment of patients (pts) with stage IV squamous non-small cell lung cancer (sq-NSCLC) [O] . L. Paz-Ares, M.A. Socinski, J. Shahidi, 2016

机译：1320_pr：表皮生长因子受体（EGFR）患者的亚群分析 - 表达肿瘤患者：一种随机，多中心，开放标签，吉西拜齐铂（GC）加上Necitumumab（N）对GC的第一个研究阶段鳞状非小细胞肺癌（SQ-NSCLC）的患者（PTS）治疗患者（PTS）治疗

A3-06: Triplets versus doublets with or without cisplatin in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: preliminary results of a multicenter randomized factorial study

著录项

引文网络

相似文献

相关主题

期刊订阅